Evidence map›Paper›PMID 19960471›Full record

ArticleElectrophoresis2009

Comparison of multidimensional shotgun technologies targeting tissue proteomics.

Xueping Fang, Brian M Balgley, Weijie Wang, Deric M Park, Cheng S Lee

Abstract readComparative Study
In one paragraph

Article in Electrophoresis, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Xueping FangDepartment of Chemistry and Biochemistry, University of Maryland, College Park, MD 20742, USA.
Brian M Balgley
Weijie Wang
Deric M Park
Cheng S Lee
California Institute for Biomedical Research · USUniversity of Maryland, College Park · USUPMC Hillman Cancer Center · US

Funding

Unraveling Cell Death via Top-Down/Bottom-Up ProteomicsR01GM073723 · NIGMS · UNIV OF MARYLAND, COLLEGE PARK · PI LEE, CHENG S · 2005 to 2008
$1.1M
Targeting Proteome Dynamic Range via Isotachophoresis-Based Analyte EnrichmentR43RR022667 · NCRR · CALIBRANT BIOSYSTEMS, INC. · PI WANG, WEIJIE · 2006 to 2006
$195k
Identification of Differentially Expressed Proteomes in Human AstrocytomasR43NS055419 · NINDS · CALIBRANT BIOSYSTEMS, INC. · PI BALGLEY, BRIAN M. · 2006 to 2006
$145k
NCRR NIH HHS R43 RR022667NCRR NIH HHS RR022667NIGMS NIH HHS GM073723NIGMS NIH HHS R01 GM073723NINDS NIH HHS NS055419NINDS NIH HHS R43 NS055419
6 · The paper itself

Abstract

A compelling need exists for the development of technologies that facilitate and accelerate the discovery of novel protein biomarkers with therapeutic and diagnostic potential. Comparisons among shotgun proteome technologies, including capillary isotachophoresis (CITP)-based multidimensional separations and multidimensional LC system, are therefore performed in this study regarding their abilities to address the challenges of protein complexity and relative abundance inherent in glioblastoma multiforme-derived cancer stem cells. Comparisons are conducted using a single processed protein digest with equal sample loading, identical second-dimension separation (RPLC) and MS conditions, and consistent search parameters and cutoff established by the target-decoy determined false-discovery rate. Besides achieving superior overall proteome performance in total peptide, distinct peptide, and distinct protein identifications; analytical reproducibility of the CITP proteome platform coupled with the spectral counting approach are determined by a Pearson R(2) value of 0.98 and a CV of 15% across all proteins quantified. In contrast, extensive fraction overlapping in strong cation exchange greatly limits the ability of multidimensional LC separations for mining deeper into the tissue proteome as evidenced by the poor coverage in various protein functional categories and key protein pathways. The CITP proteomic technology, equipped with selective analyte enrichment and ultrahigh resolving power, is expected to serve as a critical component in the overall toolset required for biomarker discovery via shotgun proteomic analysis of tissue specimens.

Indexed as

BiomarkersChromatography, Ion ExchangeElectrophoresis, CapillaryExtracellular Signal-Regulated MAP KinasesGlioblastomaHumansIsoelectric FocusingMAP Kinase Signaling SystemMass SpectrometryNeoplastic Stem CellsNeuronsOrgan SpecificityPeptide MappingProteomicsReproducibility of ResultsTumor Cells, CulturedBiomarkersExtracellular Signal-Regulated MAP Kinases

Identifiers

PMID19960471
PMCPMC3465977
OpenAlexW2049768411

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.